BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
Public ClinicalTrials.gov record NCT00097357. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-Blinded (BMS-562247 and Enoxaparin), Active-Controlled (Enoxaparin and Warfarin), Parallel-Arm, Dose-Response Study of the Oral Factor Xa Inhibitor BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to learn if BMS-562247 can prevent blood clots in the legs and lungs in men and women following unilateral total knee replacement surgery. The safety of this treatment will also be studied.
Study identification
- NCT ID
- NCT00097357
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 1,238 participants
Conditions and interventions
Conditions
Interventions
- Apixaban Drug
- Enoxaparin Drug
- Warfarin Drug
- Enoxaparin Placebo Drug
- Apixaban Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2004 (Type not available)
- Primary completion
- Dec 2005 (Actual)
- Completion
- Dec 2005 (Actual)
- Last update posted
- Mar 2, 2010
2004 – 2005
United States locations
- U.S. sites
- 72
- U.S. states
- 27
- U.S. cities
- 72
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Birmingham | Alabama | — | — |
| Local Institution | Mobile | Alabama | — | — |
| Local Institution | Northport | Alabama | — | — |
| Local Institution | Phoenix | Arizona | — | — |
| Local Institution | Scottsdale | Arizona | — | — |
| Local Institution | Tucson | Arizona | — | — |
| Local Institution | Little Rock | Arkansas | — | — |
| Local Institution | Beverly Hills | California | — | — |
| Local Institution | Encinitas | California | — | — |
| Local Institution | Fountain Valley | California | — | — |
| Local Institution | La Jolla | California | — | — |
| Local Institution | La Mesa | California | — | — |
| Local Institution | Long Beach | California | — | — |
| Local Institution | Montclair | California | — | — |
| Local Institution | Oakland | California | — | — |
| Local Institution | Pasadena | California | — | — |
| Local Institution | Sacramento | California | — | — |
| Local Institution | San Bernardino | California | — | — |
| Local Institution | San Diego | California | — | — |
| Local Institution | Santa Monica | California | — | — |
| Local Institution | Torrance | California | — | — |
| Local Institution | Wildomar | California | — | — |
| Local Institution | Yuba City | California | — | — |
| Local Institution | Aurora | Colorado | — | — |
| Local Institution | Denver | Colorado | — | — |
| Local Institution | Hartford | Connecticut | — | — |
| Local Institution | Bay Pines | Florida | — | — |
| Local Institution | Brandon | Florida | — | — |
| Local Institution | Clearwater | Florida | — | — |
| Local Institution | DeLand | Florida | — | — |
| Local Institution | Fort Myers | Florida | — | — |
| Local Institution | Hollywood | Florida | — | — |
| Local Institution | Melbourne | Florida | — | — |
| Local Institution | Pensacola | Florida | — | — |
| Local Institution | Sarasota | Florida | — | — |
| Local Institution | St. Petersburg | Florida | — | — |
| Local Institution | Tallahassee | Florida | — | — |
| Local Institution | Winter Park | Florida | — | — |
| Local Institution | Atlanta | Georgia | — | — |
| Local Institution | Cumming | Georgia | — | — |
| Local Institution | Decatur | Georgia | — | — |
| Local Institution | Suwanee | Georgia | — | — |
| Local Institution | Boise | Idaho | — | — |
| Local Institution | Meridian | Idaho | — | — |
| Local Institution | Galesburg | Illinois | — | — |
| Local Institution | Springfield | Illinois | — | — |
| Local Institution | Wichita | Kansas | — | — |
| Local Institution | Lexington | Kentucky | — | — |
| Local Institution | Madisonville | Kentucky | — | — |
| Local Institution | Covington | Louisiana | — | — |
| Local Institution | Baltimore | Maryland | — | — |
| Local Institution | Newton | Massachusetts | — | — |
| Local Institution | Port Huron | Michigan | — | — |
| Local Institution | Jackson | Mississippi | — | — |
| Local Institution | Buffalo | New York | — | — |
| Local Institution | Charlotte | North Carolina | — | — |
| Local Institution | Monroe | North Carolina | — | — |
| Local Institution | Cincinnati | Ohio | — | — |
| Local Institution | Youngstown | Ohio | — | — |
| Local Institution | Tulsa | Oklahoma | — | — |
| Local Institution | Havertown | Pennsylvania | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Pittsburgh | Pennsylvania | — | — |
| Local Institution | Charleston | South Carolina | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | Houston | Texas | — | — |
| Local Institution | Lubbock | Texas | — | — |
| Local Institution | San Antonio | Texas | — | — |
| Local Institution | Newport News | Virginia | — | — |
| Local Institution | Seattle | Washington | — | — |
| Local Institution | Marshfield | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00097357, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2010 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00097357 live on ClinicalTrials.gov.